Bioceltix S.A. (BCX.WA)

PLN 79.8

(4.04%)

Total Assets Summary of Bioceltix S.A.

  • Bioceltix S.A.'s latest annual total assets in 2023 was 12.73 Million PLN , up 112.7% from previous year.
  • Bioceltix S.A.'s latest quarterly total assets in 2024 Q2 was 52 Million PLN , up 445.68% from previous quarter.
  • Bioceltix S.A. reported annual total assets of 5.98 Million PLN in 2022, down -26.95% from previous year.
  • Bioceltix S.A. reported annual total assets of 8.19 Million PLN in 2021, up 70.67% from previous year.
  • Bioceltix S.A. reported quarterly total assets of 52 Million PLN for 2024 Q2, up 445.68% from previous quarter.
  • Bioceltix S.A. reported quarterly total assets of 12.73 Million PLN for 2023 FY, up 112.7% from previous quarter.

Annual Total Assets Chart of Bioceltix S.A. (2023 - 2018)

Historical Annual Total Assets of Bioceltix S.A. (2023 - 2018)

Year Total Assets Total Assets Growth
2023 12.73 Million PLN 112.7%
2022 5.98 Million PLN -26.95%
2021 8.19 Million PLN 70.67%
2020 4.8 Million PLN 48.73%
2019 3.22 Million PLN -2.16%
2018 3.3 Million PLN 0.0%

Peer Total Assets Comparison of Bioceltix S.A.

Name Total Assets Total Assets Difference
BIOTON S.A. 822.22 Million PLN 98.451%
Captor Therapeutics Spolka Akcyjna 97.29 Million PLN 86.911%
Mabion S.A. 208.25 Million PLN 93.885%
Molecure S.A. 168.57 Million PLN 92.445%
NanoGroup S.A. 8.63 Million PLN -47.543%
Pharmena S.A. 24.13 Million PLN 47.227%
Poltreg S.A. 127.09 Million PLN 89.98%
Pure Biologics Spólka Akcyjna 22.73 Million PLN 43.991%
Ryvu Therapeutics S.A. 403.2 Million PLN 96.841%
Synthaverse S.A. 265.9 Million PLN 95.211%
Urteste S.A. 29.59 Million PLN 56.972%